These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23734246)

  • 1. Using magnetic resonance imaging to evaluate dendritic cell-based vaccination.
    Ferguson PM; Slocombe A; Tilley RD; Hermans IF
    PLoS One; 2013; 8(5):e65318. PubMed ID: 23734246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using lymph node swelling as a potential biomarker for successful vaccination.
    Brewer KD; DeBay DR; Dude I; Davis C; Lake K; Parsons C; Rajagopalan R; Weir G; Stanford MM; Mansour M; Bowen CV
    Oncotarget; 2016 Jun; 7(24):35655-35669. PubMed ID: 27232944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.
    den Brok MH; Sutmuller RP; Nierkens S; Bennink EJ; Frielink C; Toonen LW; Boerman OC; Figdor CG; Ruers TJ; Adema GJ
    Br J Cancer; 2006 Oct; 95(7):896-905. PubMed ID: 16953240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of in vivo function of superparamagnetic iron oxide labelled murine dendritic cells during anti-tumour vaccination.
    Tavaré R; Sagoo P; Varama G; Tanriver Y; Warely A; Diebold SS; Southworth R; Schaeffter T; Lechler RI; Razavi R; Lombardi G; Mullen GE
    PLoS One; 2011; 6(5):e19662. PubMed ID: 21637760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model.
    Zhang Z; Li W; Procissi D; Li K; Sheu AY; Gordon AC; Guo Y; Khazaie K; Huan Y; Han G; Larson AC
    Radiology; 2015 Jan; 274(1):192-200. PubMed ID: 25222066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
    Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
    Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy.
    Xiang J; Xu L; Gong H; Zhu W; Wang C; Xu J; Feng L; Cheng L; Peng R; Liu Z
    ACS Nano; 2015 Jun; 9(6):6401-11. PubMed ID: 26028363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
    Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
    J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes.
    Long CM; van Laarhoven HW; Bulte JW; Levitsky HI
    Cancer Res; 2009 Apr; 69(7):3180-7. PubMed ID: 19276358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan gel vaccine protects against tumour growth in an intracaecal mouse model of cancer by modulating systemic immune responses.
    Highton AJ; Girardin A; Bell GM; Hook SM; Kemp RA
    BMC Immunol; 2016 Oct; 17(1):39. PubMed ID: 27756214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the specific immunity of dendritic cell vaccine loading human umbilical vein endothelial cell antigen against U14 cervical cancer].
    Zhao J; Zhai JM; Lu J; Yang HY; Huang YT; Li S; Dong ZM; Zhang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):196-200. PubMed ID: 19257979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs.
    Zhang Y; Wakita D; Chamoto K; Narita Y; Matsubara N; Kitamura H; Nishimura T
    Int Immunol; 2007 Feb; 19(2):151-61. PubMed ID: 17189593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-transfection gene delivery of dendritic cells induced effective lymph node targeting and anti-tumor vaccination.
    Chen YZ; Ruan GX; Yao XL; Li LM; Hu Y; Tabata Y; Gao JQ
    Pharm Res; 2013 Jun; 30(6):1502-12. PubMed ID: 23371516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell gene therapy.
    Onaitis M; Kalady MF; Pruitt S; Tyler DS
    Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic modulation of dendritic cell cancer vaccine in a mouse model: role of dendritic cell maturation.
    Botta F; Maestroni GJ
    J Immunother; 2008 Apr; 31(3):263-70. PubMed ID: 18317361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Ishida K; Primus FJ; Yamaue H
    Int J Cancer; 2007 Feb; 120(3):585-93. PubMed ID: 17096339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy.
    Jin H; Qian Y; Dai Y; Qiao S; Huang C; Lu L; Luo Q; Chen J; Zhang Z
    Theranostics; 2016; 6(11):2000-2014. PubMed ID: 27698936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.